Endocrine Pharmaceuticals Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $33.3K

  • Investors
  • 1

Endocrine Pharmaceuticals General Information

Description

Provider of therapeutic research services intended to specialize in the hormonal regulation of tissue mass and integrity. The company's services help in the treatment of benign and malignant tissue overgrowth conditions affecting the pituitary, prostate, breast, heart, and kidneys, enabling healthcare providers to cure their patients of tumor growth and improve their lives.

Contact Information

Formerly Known As
KANDAH ENTERPRISES
Ownership Status
Privately Held (backing)
Financing Status
Formerly Angel backed
Corporate Office
  • Wilderness End
  • Tadley Common Road
  • Tadley RG26 3TA
  • England, United Kingdom
+44 0118
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Wilderness End
  • Tadley Common Road
  • Tadley RG26 3TA
  • England, United Kingdom
+44 0118

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Endocrine Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Angel (individual) 05-Jan-2022 $33.3K Completed Generating Revenue
4. Secondary Transaction - Private 01-Apr-2021 Completed Pre-Clinical Trials
3. Later Stage VC 31-Dec-2019 Completed Pre-Clinical Trials
2. Grant 01-Aug-2017 Completed Startup
1. Later Stage VC 01-Nov-2013 Completed Startup
To view Endocrine Pharmaceuticals’s complete valuation and funding history, request access »

Endocrine Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Endocrine Pharmaceuticals’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Endocrine Pharmaceuticals Patents

Endocrine Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202112385-D0 Hormonal derivatives Pending 31-Aug-2021
GB-2610229-A Hormonal derivatives Pending 31-Aug-2021
GB-0800502-D0 Peptides and their uses Inactive 11-Jan-2008
GB-0800373-D0 A peptide Inactive 10-Jan-2008
EP-2234632-A2 Proteinaceous compounds Active 10-Jan-2008 C07K14/4702
To view Endocrine Pharmaceuticals’s complete patent history, request access »

Endocrine Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Endocrine Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Government of UK Government
To view Endocrine Pharmaceuticals’s complete investors history, request access »

Endocrine Pharmaceuticals FAQs

  • When was Endocrine Pharmaceuticals founded?

    Endocrine Pharmaceuticals was founded in 1995.

  • Where is Endocrine Pharmaceuticals headquartered?

    Endocrine Pharmaceuticals is headquartered in Tadley, United Kingdom.

  • What is the size of Endocrine Pharmaceuticals?

    Endocrine Pharmaceuticals has 3 total employees.

  • What industry is Endocrine Pharmaceuticals in?

    Endocrine Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Endocrine Pharmaceuticals a private or public company?

    Endocrine Pharmaceuticals is a Private company.

  • What is the current valuation of Endocrine Pharmaceuticals?

    The current valuation of Endocrine Pharmaceuticals is .

  • What is Endocrine Pharmaceuticals’s current revenue?

    The current revenue for Endocrine Pharmaceuticals is .

  • How much funding has Endocrine Pharmaceuticals raised over time?

    Endocrine Pharmaceuticals has raised $33.3K.

  • Who are Endocrine Pharmaceuticals’s investors?

    Government of UK has invested in Endocrine Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process